Good Laboratory Practice

Good Laboratory Practice
Title	Good Laboratory Practice
Established	1970s–1980s
Jurisdiction	International
Related	Food and Drug Administration, European Medicines Agency, Organisation for Economic Co-operation and Development

Good Laboratory Practice is a system of procedural and managerial controls designed to ensure the reliability, integrity, and traceability of non-clinical laboratory studies used in regulatory submissions. It integrates organizational structures, standardized methods, documentation practices, and facility requirements to support decision-making by regulatory authorities, industry sponsors, and research institutions. Originating from legislative and regulatory responses to scientific failures, the framework is implemented through harmonized guidelines and national laws that affect pharmaceutical, chemical, and environmental testing worldwide.

History and Development

GLP emerged in response to high-profile scientific and regulatory crises during the 1960s and 1970s that exposed data integrity failures in safety testing, prompting legislative action by bodies such as the United States Congress and regulatory responses from agencies like the Food and Drug Administration and the Environmental Protection Agency. International harmonization advanced through multilateral organizations, notably the Organisation for Economic Co-operation and Development with its Principles on Good Laboratory Practice and Compliance Monitoring, and later engagement by the European Medicines Agency and World Health Organization. National statutes and guidance—such as regulations promulgated by the United States Department of Health and Human Services and implementing rules in member states of the European Union—codified procedures for study conduct, recordkeeping, and inspections. Influential incidents, policy reforms, and cross-border regulatory cooperation involving entities like the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use shaped modern expectations for preclinical data quality.

Principles and Scope

The GLP framework rests on core principles that emphasize study planning, standardized methods, unbiased data collection, and secure archiving. Key elements align with expectations set by organizations including the Organisation for Economic Co-operation and Development, the World Health Organization, and the European Commission for studies used in regulatory dossiers submitted to the Food and Drug Administration, the European Medicines Agency, and analogous national authorities. Scope commonly covers non-clinical laboratory safety tests for pharmaceutical substances, agrochemicals regulated by agencies such as the United States Environmental Protection Agency, and industrial chemicals addressed under instruments like the Registration, Evaluation, Authorisation and Restriction of Chemicals framework. GLP principles interface with complementary regimes such as Good Manufacturing Practice and Good Clinical Practice within product development lifecycles overseen by authorities like the Pharmaceuticals and Medical Devices Agency.

Organizational Structure and Responsibilities

GLP specifies distinct organizational roles to separate study conduct, sponsor oversight, and quality assurance functions. Typical role definitions mirror governance patterns found in institutions such as national laboratories, university research centers affiliated with the National Institutes of Health, and commercial contract research organizations that may work with multinational firms like Pfizer, Novartis, or Bayer. Responsibilities allocate authority to positions analogous to study directors, principal investigators, and quality assurance personnel; these roles interact with corporate compliance offices, legal departments, and inspection teams from regulators such as the Food and Drug Administration and the European Medicines Agency. Contractual relationships between sponsors and laboratories are governed by agreements referencing standards promulgated by bodies like the Organisation for Economic Co-operation and Development.

Quality Assurance and Documentation

Robust quality assurance systems are central to GLP, mandating independent monitoring, audit trails, and retention of raw data, final reports, and archiving consistent with guidance from the International Organization for Standardization and regulatory authorities including the Food and Drug Administration. Documentation practices echo recordkeeping traditions institutionalized by historical repositories such as the National Archives and Records Administration and standards bodies like the British Standards Institution. Quality control activities include routine audits, deviation management, equipment calibration traceable to national metrology institutes such as the National Institute of Standards and Technology, and validation of computerized systems consistent with regulatory guidance from agencies like the European Medicines Agency.

Facility Design and Safety Practices

GLP-compliant facilities incorporate design features that support study integrity and personnel safety, reflecting construction and occupational health norms seen in laboratory complexes affiliated with universities like Harvard University and national laboratories such as Lawrence Berkeley National Laboratory. Requirements cover controlled access, environmental monitoring, containment for hazardous substances overseen by regulators such as the Environmental Protection Agency, and emergency response coordination with local authorities including Federal Emergency Management Agency units. Safety practices integrate training protocols, personal protective equipment standards from organizations like the Occupational Safety and Health Administration, and waste handling consistent with international agreements such as the Basel Convention where applicable.

Test Methods and Study Conduct

GLP prescribes validated test methods, study plans, and statistical approaches to ensure reproducibility and relevance for regulatory decision-making. Test method validation standards developed by bodies such as the Organisation for Economic Co-operation and Development and the International Organization for Standardization inform assay selection for toxicology, pharmacology, and environmental fate studies submitted to agencies including the Food and Drug Administration and the European Chemicals Agency. Study conduct requires adherence to protocols, chain-of-custody documentation, and controls comparable to practices in institution-led research at centers like the National Institutes of Health and industry laboratories operated by firms such as GlaxoSmithKline.

Compliance, Inspections, and Enforcement

Regulatory compliance is enforced through routine and for-cause inspections by authorities such as the Food and Drug Administration, European Medicines Agency-coordinated national regulators, and agencies within the Organisation for Economic Co-operation and Development framework. Enforcement actions range from warning letters and administrative sanctions to criminal prosecution under statutes enforced by entities like the United States Department of Justice when data falsification or gross noncompliance is uncovered. International cooperation, mutual acceptance schemes, and professional societies such as the Society of Toxicology support capacity building and harmonized enforcement practices among regulatory agencies and industry stakeholders.

Category:Laboratory standards